An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 1, 2009, Pages e6-

  Yamazaki, Yutaka ^a   Hata, Hironobu ^a   Kitamori, Shogo ^a   Onodera, Makiko ^a   Kitagawa, Yoshimasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57649159117     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.08.024     Document Type: Article

References (24)

1. Merskey H., and Bogduk N. Classification of chronic pain. 2nd ed. (2004), International Association for the Study of Pain Publishing, Seattle, WA
2. Lipton J.A., Ship J.A., and Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 124 (1993) 115-121
3. Tammiala-Salonen T., Hiidenkari T., and Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 21 (1993) 67-71
4. Grushka M., Kawajec J., and Epstein J.B. Burning mouth syndrome. Evolving concepts. Oral Maxillofac Surg Clin North Am 12 (2000) 287-295
5. Sardella A., Lodi G., Demarosi F., Uglietti D., and Carrassi A. Causative or precipitating aspects of burning mouth syndrome: a case-control study. J Oral Pathol Med 35 (2006) 466-471
6. Scala A., Checchi L., Montevecchi M., Marini I., and Giamberardino M.A. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 14 (2003) 275-291
7. Patton L.L., Siegel M.A., Benoliel R., and De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 suppl 1 (2007) S39.e1-S39.e13
8. Lauria G., Majorana A., Borgna M., Lombardi R., Penza P., Padovani A., et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 115 (2005) 332-337
9. Albuquerque R.J., de Leeuw R., Carlson C.R., Okeson J.P., Miller C.S., and Andersen A.H. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 122 (2006) 223-234
10. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
11. Gremeau-Richard C., Woda A., Navez M.L., Attal N., Bouhassira D., Gagnieu M.C., et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 108 (2004) 51-57
12. Bourin M., Chue P., and Guillon Y. Paroxetine: a review. CNS Drug Rev 7 (2001) 25-47
13. Saarto T., and Wiffen P.J. Antidepressants of neuropathic pain. Cochrane Database Syst Rev 17 (2007) CD005454.
14. Maina G., Vitalucci A., Gandolfo S., and Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 63 (2002) 38-43
15. Bogetto F., Bonatto R.R., Ferro G., Maina G., and Ravizza L. Psychopharmacological treatment of burning mouth syndrome (BMS). A study on a sample of 121 patients. Minerva Psichiatr 40 (1999) 1-10
16. Mackay F.J., Dunn N.R., Wilton L.V., Pearce G.L., Freemantle S.N., and Mann R.D. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf 6 (1997) 235-246
17. Salort-Llorca C., Minguez-Serra M.P., and Silvestre F.J. Drug-induced burning mouth syndrome: a new etiological diagnosis. Med Oral Pathol Oral Cir Bucal 13 (2008) E167-E170
18. Kyle C.J., Petersen H.E., and Overo K.F. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress Anxiety 8 (1998) 147-153
19. Zakrzewska J.M., Forssell H., and Glenny A.M. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain 17 (2003) 293-300
20. Tatsumi M., Groshan K., Blakely B.D., and Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340 (1997) 249-258
21. Nemeroff C.B., and Owens M.J. Neuropharmacology of paroxetine. Psychopharmacol Bull 37 Suppl 1 (2003) 8-18
22. Danhauer S.C., Miller C.S., Rhodus N.L., and Carlson C.R. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain 16 (2002) 305-311
23. Loldrup D., Langemark M., Hansen H.J., Olesen J., and Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berl) 99 (1989) 1-7
24. Dunner D.L., and Dunbar G.C. Optimal dose regimen for paroxetine. J Clin Psychiatry 53 Suppl (1992) 21-26